Variant report
Variant | esv3341565 |
---|---|
Chromosome Location | chr4:173051627-173053825 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:173044514..173046349-chr4:173049744..173052591,2 | MCF-7 | breast: | |
2 | chr4:173050386..173053411-chr4:173069490..173071981,3 | K562 | blood: | |
3 | chr4:173053655..173055804-chr4:173057381..173059355,2 | K562 | blood: | |
4 | chr4:173050637..173053046-chr4:173107907..173109625,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs190550240 | chr4:173051646-173051647 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs574170799 | chr4:173051701-173051702 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72994118 | chr4:173051754-173051755 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs547983469 | chr4:173051788-173051789 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs541567577 | chr4:173051791-173051792 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs371454215 | chr4:173051802-173051803 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566448258 | chr4:173051808-173051809 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373580826 | chr4:173051831-173051832 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114481566 | chr4:173051880-173051881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs143431075 | chr4:173051881-173051882 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs568883654 | chr4:173051890-173051891 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs141850314 | chr4:173051963-173051964 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs531380828 | chr4:173051971-173051972 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201550304 | chr4:173051973-173051974 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs60679939 | chr4:173052016-173052017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs557642989 | chr4:173052031-173052032 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs76468690 | chr4:173052054-173052055 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs115372895 | chr4:173052085-173052086 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs6553608 | chr4:173052098-173052099 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs184984413 | chr4:173052099-173052100 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543153281 | chr4:173052128-173052129 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562820267 | chr4:173052159-173052160 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs57118139 | chr4:173052184-173052185 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs531774556 | chr4:173052201-173052202 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs113371697 | chr4:173052208-173052209 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs545387980 | chr4:173052244-173052245 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs565600009 | chr4:173052287-173052288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs527944193 | chr4:173052290-173052291 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190323075 | chr4:173052359-173052360 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547684791 | chr4:173052394-173052395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11132928 | chr4:173052396-173052397 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs11938066 | chr4:173052420-173052421 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs549092603 | chr4:173052426-173052427 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs575926986 | chr4:173052428-173052429 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35699070 | chr4:173052580-173052581 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs11132929 | chr4:173052581-173052582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531051488 | chr4:173052582-173052583 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs202208402 | chr4:173052583-173052584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544517717 | chr4:173052593-173052594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs62331106 | chr4:173052603-173052604 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs201260944 | chr4:173052605-173052606 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs568822588 | chr4:173052624-173052625 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs34442141 | chr4:173052630-173052631 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs372155453 | chr4:173052631-173052632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs386402284 | chr4:173052639-173052640 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs397941300 | chr4:173052640-173052641 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs537466933 | chr4:173052663-173052664 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs557283082 | chr4:173052664-173052665 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs139218667 | chr4:173052672-173052673 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533872530 | chr4:173052674-173052675 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Schizophrenia | 23813976 | CNVD |
Lung cancer | 16773561 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Developmental delay | 22127048 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Prostate cancer | 22341455 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:173043600-173052800 | Weak transcription | K562 | blood |
2 | chr4:173050200-173052800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
3 | chr4:173051000-173052200 | Enhancers | Muscle Satellite Cultured Cells | -- |
4 | chr4:173051400-173062800 | Weak transcription | NHDF-Ad | bronchial |
5 | chr4:173052200-173053600 | Weak transcription | Muscle Satellite Cultured Cells | -- |
6 | chr4:173052800-173053000 | Enhancers | Foreskin Fibroblast Primary Cells skin01 | Skin |
7 | chr4:173052800-173053600 | Enhancers | NH-A | brain |
8 | chr4:173052800-173053800 | Enhancers | Fetal Brain Male | brain |
9 | chr4:173052800-173054800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
10 | chr4:173053200-173054200 | Weak transcription | Foreskin Fibroblast Primary Cells skin01 | Skin |
11 | chr4:173053600-173053800 | Enhancers | Muscle Satellite Cultured Cells | -- |
12 | chr4:173053600-173055800 | Weak transcription | NH-A | brain |
13 | chr4:173053800-173054200 | Weak transcription | Muscle Satellite Cultured Cells | -- |